Biological Products, (No Diagnostic Substances)
Industry (SEC)
Show active companies only

140 companies

ADMA
ADMA Biologics, Inc.
ADMA Biologics, Inc.
New Jersey
NASDAQ
AIM
AIM ImmunoTech, Inc.
AIM ImmunoTech, Inc.
Florida
NYSE
XLRN
Acceleron Pharma, Inc.
Acceleron Pharma, Inc.
Massachusetts
NASDAQ
ACOR
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc.
New York
NASDAQ
ADAP
Adaptimmune Therapeutics PLC
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.
United Kingdom
NASDAQ
ADPT
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp.
Washington
NASDAQ
ADVM
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc.
California
NASDAQ
AERI
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc.
North Carolina
NASDAQ
GNMX
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc.
Pennsylvania
NASDAQ
AGEN
Agenus, Inc.
Agenus, Inc.
Massachusetts
NASDAQ
ALEC
Alector, Inc.
Alector, Inc.
California
NASDAQ
ALNA
Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc.
Massachusetts
NASDAQ
ALLO
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc.
California
NASDAQ
AMGN
Amgen, Inc.
Amgen, Inc.
California
NASDAQ
AGTC
Applied Genetic Technologies Corp.
Applied Genetic Technologies Corp.
Florida
NASDAQ
APTO
Aptose Biosciences, Inc.
Aptose Biosciences, Inc.
Ontario, Canada
NASDAQ
ARMP
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc.
California
NYSE
ATRA
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc.
California
NASDAQ
BOLD
Audentes Therapeutics, Inc.
Audentes Therapeutics, Inc.
California
NASDAQ
AUTL
Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company.
United Kingdom